Novel Adjuvants for Peptide-Based Melanoma Vaccines - Related Studies

Home

Novel Adjuvants for Peptide-Based Melanoma Vaccines

This study is currently recruiting participants.

Study NCT00028431. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma

2	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas

3	Sponsors listed in this trial
		FDA Office of Orphan Products Development